Showing results (101-110 of 170) with videos related to

Sort By:
Pageof 17
Blood Advances|February 28, 2025
Estrogen receptor β stimulation as a possible novel therapeutic target for cutaneous T-cell lymphomaDeniz Özistanbullu, Raphael Wilhelm, Gabi Reichenbach, et al.
Cancers|May 11, 2024
Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood NeutrophilsSimone Wendlinger, Jonas Wohlfarth, Claudia Siedel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 10, 2016
Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue neviInga Möller, Rajmohan Murali, Hansgeorg Müller, et al.
Cancers|November 26, 2022
Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg RegistryMaximilian Haist, Henner Stege, Berenice Mareen Lang, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2021
Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanomaJudith M Versluis, Irene L M Reijers, Elisa A Rozeman, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2020
Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'Benedikt C Westphalen, Carsten Bokemeyer, Reinhard Büttner, et al.
Oncogene|September 26, 2020
The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expressionChristina Jessen, Julia K C Kreß, Apoorva Baluapuri, et al.
Cancers|July 14, 2023
Tebentafusp in Patients with Metastatic Uveal Melanoma: A Real-Life Retrospective Multicenter StudyDirk Tomsitz, Theresa Ruf, Markus Heppt, et al.
Cancer|December 19, 2018
The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomasSilke Appenzeller, Anja Gesierich, Alexander Thiem, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2024
Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockadeEleftheria Chorti, Bernd Kowall, Jessica C Hassel, et al.
Pageof 17